[Form 4] Symbotic Inc. Insider Trading Activity
Rhea-AI Filing Summary
Symbotic Inc. (SYM) director Andrew D. Ross received restricted stock unit grants recorded on Form 4. The filing shows two grants totaling 12,809 restricted stock units that each convert into one share of Class A common stock upon settlement.
The first grant of 5,104 RSUs vests in full upon the earliest of August 26, 2026, the 2026 annual meeting, or a change of control, subject to continued service. The second grant of 7,705 RSUs vests in three equal annual installments on August 26, 2026, 2027, and 2028, subject to continued service. Both grants have an effective transaction date of 08/26/2025 and report a $0 price per unit. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Ross on 08/28/2025.
Positive
- Total grant of 12,809 RSUs is clearly disclosed with share-equivalent amounts
- Detailed vesting schedules provided: full cliff vesting for 5,104 RSUs and 3-year graded vesting for 7,705 RSUs
- Grants filed promptly with transaction date 08/26/2025 and signed filing 08/28/2025
- Reporting person identified as a director, clarifying role and governance context
Negative
- None.
Insights
TL;DR: Director received time-based and event-based RSUs aligning compensation with service and potential corporate milestones.
The 12,809 RSU awards combine cliff and graded vesting: 5,104 cliff-vesting tied to service, annual meeting, or change of control; 7,705 graded over three years. These structures are common for non-employee directors and aim to retain senior governance personnel while linking payout to tenure or corporate events. The grants are documented as having a $0 per-unit price, reflecting restricted equity instruments rather than open-market purchases. From a governance perspective, disclosures are complete for the grant details provided and consistently report direct beneficial ownership.
TL;DR: The Form 4 reports routine equity compensation to a director with no immediate cash proceeds or exercises.
The transaction codes indicate acquisition of derivative securities in the form of RSUs that convert to Class A shares. There is no exercise price and no sale or disposition reported, so there is no immediate cash flow or liquidity event. Vesting dates span through 2028, creating multi-year potential share issuance. For investors, this is a standard compensation disclosure rather than an operational or financial development that directly alters near-term earnings or cash position.